ICMC is a collaborative launched in 2017 between academics and academic-clinicians that aims to promote microbiome research within the field of oncology, establish expert consensus and deliver education for academics and clinicians.
ICMC organises congresses every two to three years. These events usually span a few days and include cutting-edge and educational keynotes from international experts in the microbiome and oncology as well as round-table discussion between to generate expert consensus on questions of interest. Click the links below for more details on the previous Congress in 2017 and our upcoming event to be held in London, September 2020.
ICMC Congress 2020
Three-day meeting in London, UK, from 23-25th September 2020.
Focus on the role of the microbiome in cancer therapy.
Two-day educational event with keynotes from invited experts.
ICMC is active within the literature and several publications in high-impact journals. In particular, we aim to publish expert consensus on key questions related to the microbiome and oncology.
International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis
Scott AJ, Alexander JL, Merrifield CA, Marchesi JM, Kinross JA and the ICMC collaborators
The result of the 2017 Congress roundtable discussion is a an expert consensusu statement regarding the role of the microbiome in the aetiopathogenesis of cancer.
However, expert opinion was that the microbiome is one apex of a tripartite, multidirectional interactome alongside environmental factors and an epigenetically/genetically vulnerable host that combine to cause cancer.
Cancer and the Microbiome - eCancer Special Issue
A collection of articles by ICMC Collaborators on the role of the microbiome in various aspects of oncology.
Highlights from the Inaugural International Cancer Microbiome Consortium Meeting
Scott AJ, Alexander JL, Merrifield CA, Marchesi JM, Kinross JA
The conference report from the inaugral ICMC Congress in 2017